Coronavirus (COVID-19)

Please find below the latest guidance on coronavirus for children with neuroblastoma, information on our Emergency Fund for families and details on how you can support the charity through this time.

Emergency Fund Frequently Asked Questions

Emergency Fund Frequently Asked Questions Read more

A Message from Nick Bird, Chair of Trustees

A Message from Nick Bird, Chair of Trustees Read more

Important Update - Shielding Guidelines

The Government have confirmed revised amendments to the shielding guidelines for children and young people [0-18 years]. Read more

Emergency Fund for Families

If your family is facing financial strain due to the impact of the Coronavirus pandemic you can make an application to our Emergency Fund. Read more

Latest

Kathryn's RSR for Jude

To help Jude's family reach their fundraising target.
St Mary Magdalene - Y5 and Y6 Ticket Sales
Leah Ambler- Research Officer
Solihull Half Marathon for Jude Mellon-Jameson

For Jude

Beau's Campaign

Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.
Flora's Campaign

In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £252,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Joseph Yeandle

We are devastated to share the news that beautiful Joseph has sadly passed away.
Jude's Campaign

Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.
Maysaa's Campaign

Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.
Chloe’s Journey

Beautiful Chloe passed away on the 4th of February 2022.
Eden's Campaign

Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.
Kayla's Campaign

Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Peter's Campaign

11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. Thanks to your incredible fundraising and support, Peter was able to enrol on the DFMO study in Charlotte at the end of January 2022.
Dulcie's Campaign

In December 2021, five-year-old Dulcie was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.